Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.
about
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionAn open source multivariate framework for n-tissue segmentation with evaluation on public data.The Alzheimer's disease neuroimaging initiative: progress report and future plansUnderstanding cognitive deficits in Alzheimer's disease based on neuroimaging findings2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Diagnosis of regional cerebral blood flow abnormalities using spect: agreement between individualized statistical parametric maps and visual inspection by nuclear medicine physicians with different levels of expertise in nuclear neurology.Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.Total and phosphorylated tau protein as biological markers of Alzheimer's disease.Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjectsBoosting power for clinical trials using classifiers based on multiple biomarkers.Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohortRelationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scansRole of structural MRI in Alzheimer's diseaseOptimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjectsThe diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometryMapping ventricular expansion onto cortical gray matter in older adults.Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's diseaseHeritability of brain ventricle volume: converging evidence from inconsistent resultsCarriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer DiseaseCerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer typeSurface-based TBM boosts power to detect disease effects on the brain: an N=804 ADNI study.Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E studySurface fluid registration of conformal representation: application to detect disease burden and genetic influence on hippocampusInfluence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.
P2860
Q24193707-86A12F37-56CC-4438-921D-CD727FDC3A02Q26801629-C9484780-6642-4C39-81DC-1BBB19A18154Q27006831-9CD0A2A3-B1ED-4945-AF30-7E1164737E17Q28731438-C494F4F6-04DB-4960-8339-F00BC38BD339Q28749585-49757E81-7146-434E-82EE-7BC096EFE927Q30666527-84046570-51B7-4DFB-BC0A-A9DCCF733DB6Q30971403-E38F483F-E040-4A53-B357-8023EDB003BBQ33555037-3AD13CFA-43FC-4EFF-8395-AFACB8997FF0Q33575184-2FA7C5CE-5AE4-4BEF-820A-7EC9FF3870A8Q33624674-4F367E53-F8B5-4F3D-9C8B-FE669179AC62Q33651118-2143F269-9093-46DD-9F11-EF50260A0778Q33689474-4250178F-AD2F-4ADD-8763-14656D82E185Q33754677-34B92C48-6449-4053-B39E-7E5AD1A2FFACQ33759240-BDC9C71F-8BC4-40CB-B3F3-02F9E8FFDC9AQ33842486-DEFC1636-7A8D-4C74-840F-3EBA3CFCA35BQ33881726-997BC00E-C31E-46E6-BC4C-807E6BEAB4FAQ33987747-7E63E5AA-D764-4CE6-A28B-35E53108C77FQ33990243-A406CC64-693F-4144-9B42-F312FF1B551FQ33990250-6BB2D048-B2DE-42D2-A004-967683D7E31AQ33996059-5D37BC24-4742-461C-A3E4-27336B0FDE1FQ34039952-5061757D-D903-4771-84DD-FC9489BFB277Q34065449-DCCA78D3-39A8-40AC-80CA-F4AED5C74DA3Q34081087-D6A26B8E-829C-46E7-BC76-D92749E02BAEQ34173192-3D82CC7A-3B6E-4E2A-90CE-341B2C94D471Q34271896-9D558FD9-FF41-4309-9F9E-743A0C229851Q34460995-D09CCC90-5BC6-4F01-97EC-F6B6DD6EF48CQ34514638-C93BBE79-DA26-41FF-B830-06BBA3F940DDQ34615211-5FE8121C-1A70-4908-BA6E-D604B84DCA26Q34714892-7A2096A7-51BC-47A6-9844-3485E1BD1710Q34725320-B784FF7C-1B0D-4118-B16A-ED077777EB6CQ34802970-7FC60D9B-8599-4CFE-8F71-3243374EBD70Q35566796-E078FB65-AF7F-45D5-800B-45BF368DF1D4Q35733219-4AD7F8F3-B257-40B5-9BD2-373235ED617DQ35776079-BF3B8709-059F-4701-9553-40FE28E93D65Q35842864-009CD240-7ECA-4F62-B103-C6C7FA798DB9Q36087030-E9AB3553-ABE0-44DC-B2C7-AB44AF5BF629Q36494813-B70C12BC-D624-4575-B805-04F0494F0220Q36868857-4BEF1E0D-6A65-4B62-8909-2D890610B6C6Q36932677-0D5A205B-3B12-4713-AF50-B951A8C38FFFQ36945742-1172A717-FFEE-4CE5-A646-5A642D553B9A
P2860
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mapping correlations between v ...... pairment and elderly controls.
@en
Mapping correlations between v ...... pairment and elderly controls.
@nl
type
label
Mapping correlations between v ...... pairment and elderly controls.
@en
Mapping correlations between v ...... pairment and elderly controls.
@nl
prefLabel
Mapping correlations between v ...... pairment and elderly controls.
@en
Mapping correlations between v ...... pairment and elderly controls.
@nl
P2093
P2860
P50
P1433
P1476
Mapping correlations between v ...... pairment and elderly controls.
@en
P2093
Christina Avedissian
Leslie M Shaw
Natasha Leporé
Neelroop Parikshak
Sarah K Madsen
Yi-Yu Chou
P2860
P304
P356
10.1016/J.NEUROIMAGE.2009.02.015
P407
P50
P577
2009-02-21T00:00:00Z